{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4416"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4416","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"TRANSITIONING FROM MICROFLUIDIC-BASED TO BIOPRINTED DECELLULARIZED EXTRACELLULAR MATRIX IN VITRO BLOOD–BRAIN BARRIER MODELS","abstract":"The blood–brain barrier (BBB) regulates transport between the vasculature and central nervous system but limits therapeutic delivery. In vitro BBB models are essential for studying barrier function, disease mechanisms, and drug transport, yet traditional systems often lack biological relevance. This thesis aimed to improve model fidelity and scalability by refining a PDMS-based microfluidic fabrication protocol and developing a spinal cord-derived decellularized extracellular matrix (dECM) bioink for bioprinting applications. A multi-step protocol was optimized to decellularize bovine spinal cord tissue, followed by enzymatic digestion to generate a printable dECM solution. UV–Vis spectroscopy confirmed protein retention, and DNA quantification revealed residual nucleic acids above the 50 ng/mg threshold, indicating room for improvement. Despite this, the approach offers a biologically relevant, scalable alternative to PDMS models and lays the groundwork for future integration with light-based bioprinting.","abstract_html":"The blood–brain barrier (BBB) regulates transport between the vasculature and central nervous system but limits therapeutic delivery. In vitro BBB models are essential for studying barrier function, disease mechanisms, and drug transport, yet traditional systems often lack biological relevance. This thesis aimed to improve model fidelity and scalability by refining a PDMS-based microfluidic fabrication protocol and developing a spinal cord-derived decellularized extracellular matrix (dECM) bioink for bioprinting applications. A multi-step protocol was optimized to decellularize bovine spinal cord tissue, followed by enzymatic digestion to generate a printable dECM solution. UV–Vis spectroscopy confirmed protein retention, and DNA quantification revealed residual nucleic acids above the 50 ng/mg threshold, indicating room for improvement. Despite this, the approach offers a biologically relevant, scalable alternative to PDMS models and lays the groundwork for future integration with light-based bioprinting.","abstract_has_math":false,"creators":["Mowen, Connor O"],"institution":null,"degree_name":"M.S. Biomedical Engineering","degree_level":"Thesis","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":["Peter A. Galie, Ph.D.","Patrick Hwang, Ph.D.","Grace Chen, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:59Z","subjects":["Bioprinting;Blood–brain barrier (BBB);Decellularized extracellular matrix (dECM);Microfluidic devices;PDMS microfluidics;Spinal cord-derived ECM"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3410","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3410","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4416","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Peter A. Galie, Ph.D.","Patrick Hwang, Ph.D.","Grace Chen, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Mowen, Connor O"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-06-30T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2025-06-30T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S. Biomedical Engineering"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Bioprinting;Blood–brain barrier (BBB);Decellularized extracellular matrix (dECM);Microfluidic devices;PDMS microfluidics;Spinal cord-derived ECM"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3410"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The blood–brain barrier (BBB) regulates transport between the vasculature and central nervous system but limits therapeutic delivery. In vitro BBB models are essential for studying barrier function, disease mechanisms, and drug transport, yet traditional systems often lack biological relevance. This thesis aimed to improve model fidelity and scalability by refining a PDMS-based microfluidic fabrication protocol and developing a spinal cord-derived decellularized extracellular matrix (dECM) bioink for bioprinting applications. A multi-step protocol was optimized to decellularize bovine spinal cord tissue, followed by enzymatic digestion to generate a printable dECM solution. UV–Vis spectroscopy confirmed protein retention, and DNA quantification revealed residual nucleic acids above the 50 ng/mg threshold, indicating room for improvement. Despite this, the approach offers a biologically relevant, scalable alternative to PDMS models and lays the groundwork for future integration with light-based bioprinting."]},{"key":"dc:title","label":"Title","values":["TRANSITIONING FROM MICROFLUIDIC-BASED TO BIOPRINTED DECELLULARIZED EXTRACELLULAR MATRIX IN VITRO BLOOD–BRAIN BARRIER MODELS"]}]}],"canonical_facts":{"dc:contributor":["Peter A. Galie, Ph.D.","Patrick Hwang, Ph.D.","Grace Chen, Ph.D."],"dc:creator":["Mowen, Connor O"],"dc:date.available":["2025-06-30T07:00:00Z"],"dc:date.created":["2025-06-30T07:00:00Z"],"dc:description.abstract":["The blood–brain barrier (BBB) regulates transport between the vasculature and central nervous system but limits therapeutic delivery. In vitro BBB models are essential for studying barrier function, disease mechanisms, and drug transport, yet traditional systems often lack biological relevance. This thesis aimed to improve model fidelity and scalability by refining a PDMS-based microfluidic fabrication protocol and developing a spinal cord-derived decellularized extracellular matrix (dECM) bioink for bioprinting applications. A multi-step protocol was optimized to decellularize bovine spinal cord tissue, followed by enzymatic digestion to generate a printable dECM solution. UV–Vis spectroscopy confirmed protein retention, and DNA quantification revealed residual nucleic acids above the 50 ng/mg threshold, indicating room for improvement. Despite this, the approach offers a biologically relevant, scalable alternative to PDMS models and lays the groundwork for future integration with light-based bioprinting."],"dc:identifier":["https://rdw.rowan.edu/etd/3410"],"dc:subject":["Bioprinting;Blood–brain barrier (BBB);Decellularized extracellular matrix (dECM);Microfluidic devices;PDMS microfluidics;Spinal cord-derived ECM"],"dc:title":["TRANSITIONING FROM MICROFLUIDIC-BASED TO BIOPRINTED DECELLULARIZED EXTRACELLULAR MATRIX IN VITRO BLOOD–BRAIN BARRIER MODELS"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S. Biomedical Engineering"]},"updated_at":"2026-11-19T08:59:59Z"}